30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Ocular Therapeutix Inc (OCUL)

Track

Over the last 90 days, Ocular Therapeutix Inc. has seen significant insider selling, with a net value of -$483,047. Executives have been net sellers, contributing to a negative net insider count. The stock price has increased by 16.4% in the same period. The last earnings report showed a -29% EPS miss.
Stock chart
Ticker: OCUL Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Waheed Nadia
Chief Medical Officer
2 sales — total 200,000 USD
Sale 3 Jun 2026
Value US$1,960,409.83 | Price 254.12 | Shares 39,453
Sale 3 Jun 2026
Value US$1,638,606.15 | Price 45.85 | Shares 31,044
Proposed sale 3 Jun 2026
Value US$1,088,067.05 | Price 256.20 | Shares 60,171
Sale 26 May 2026
Value US$173,479.20 | Price 8.20 | Shares 21,156
Sale 26 May 2026
Value US$24,747.60 | Price 8.20 | Shares 3,018
Sale 26 May 2026
Value US$24,329.40 | Price 8.20 | Shares 2,967
Sale 26 May 2026
Value US$15,235.60 | Price 8.20 | Shares 1,858
Proposed sale 26 May 2026
Value US$15,236.53 | Price 8.20 | Shares 1,858
Proposed sale 26 May 2026
Value US$24,333.55 | Price 8.20 | Shares 2,967
Proposed sale 26 May 2026
Value US$24,745.19 | Price 8.20 | Shares 3,018
Proposed sale 26 May 2026
Value US$173,513.05 | Price 8.20 | Shares 21,156
Sale 23 Feb 2026
Value US$166,063.68 | Price 8.28 | Shares 20,056
Sale 23 Feb 2026
Value US$23,266.80 | Price 8.28 | Shares 2,810
Sale 23 Feb 2026
Value US$25,311.96 | Price 8.28 | Shares 3,057
Sale 23 Feb 2026
Value US$14,564.52 | Price 8.28 | Shares 1,759
Proposed sale 23 Feb 2026
Value US$23,267.64 | Price 8.28 | Shares 2,810
Proposed sale 23 Feb 2026
Value US$166,085.74 | Price 8.28 | Shares 20,056
Proposed sale 23 Feb 2026
Value US$25,298.20 | Price 8.28 | Shares 3,057
Proposed sale 23 Feb 2026
Value US$14,562.59 | Price 8.28 | Shares 1,759
Sale 20 Feb 2026
Value US$27,167.40 | Price 7.74 | Shares 3,510
Buy 20 Feb 2026
Value US$461,354.14 | Price 7.66 | Shares 60,229
Proposed sale 20 Feb 2026
Value US$27,170.21 | Price 7.74 | Shares 3,510
Sale 12 Feb 2026
Value US$103,471.84 | Price 9.04 | Shares 11,446
Sale 12 Feb 2026
Value US$93,545.92 | Price 9.04 | Shares 10,348
Sale 12 Feb 2026
Value US$1,128,933.28 | Price 9.04 | Shares 124,882
Sale 12 Feb 2026
Value US$71,081.52 | Price 9.04 | Shares 7,863
Proposed sale 12 Feb 2026
Value US$103,481.00 | Price 9.04 | Shares 11,446
Proposed sale 12 Feb 2026
Value US$1,128,583.61 | Price 9.04 | Shares 124,882
Proposed sale 12 Feb 2026
Value US$62,034.09 | Price 9.04 | Shares 6,864
Proposed sale 12 Feb 2026
Value US$93,560.41 | Price 9.04 | Shares 10,348
Proposed sale 12 Feb 2026
Value US$71,082.31 | Price 9.04 | Shares 7,863
Sale 4 Feb 2026
Value US$51,538.90 | Price 8.54 | Shares 6,035
Sale 4 Feb 2026
Value US$51,538.90 | Price 8.54 | Shares 6,035
Proposed sale 4 Feb 2026
Value US$37,636.39 | Price 8.54 | Shares 4,408
Proposed sale 4 Feb 2026
Value US$51,540.71 | Price 8.54 | Shares 6,035
Sale 2 Feb 2026
Value US$49,858.70 | Price 9.14 | Shares 5,455
Proposed sale 2 Feb 2026
Value US$49,872.88 | Price 9.14 | Shares 5,455
Proposed sale 2 Feb 2026
Value US$27,903.83 | Price 9.14 | Shares 3,052
Sale 24 Nov 2025
Value US$36,144.14 | Price 12.02 | Shares 3,007
Sale 24 Nov 2025
Value US$41,766.76 | Price 12.04 | Shares 3,469
Sale 24 Nov 2025
Value US$22,611.12 | Price 12.04 | Shares 1,878
Sale 24 Nov 2025
Value US$235,141.20 | Price 12.04 | Shares 19,530
Proposed sale 24 Nov 2025
Value US$235,082.61 | Price 12.04 | Shares 19,530
Proposed sale 24 Nov 2025
Value US$22,616.19 | Price 12.04 | Shares 1,878
Proposed sale 24 Nov 2025
Value US$36,150.15 | Price 12.02 | Shares 3,007
Proposed sale 24 Nov 2025
Value US$41,771.96 | Price 12.04 | Shares 3,469
Sale 5 Nov 2025
Value US$277,790.10 | Price 10.74 | Shares 25,865
Proposed sale 5 Nov 2025
Value US$277,909.08 | Price 10.74 | Shares 25,865
Sale 8 Oct 2025
Value US$137,368.88 | Price 12.34 | Shares 11,132
Proposed sale 8 Oct 2025
Value US$137,400.05 | Price 12.34 | Shares 11,132
Sale 2 Oct 2025
Value US$115,942.08 | Price 11.04 | Shares 10,502
Sale 2 Oct 2025
Value US$106,472.59 | Price 11.03 | Shares 9,653
Proposed sale 2 Oct 2025
Value US$115,889.57 | Price 11.04 | Shares 10,502
Proposed sale 2 Oct 2025
Value US$106,516.03 | Price 11.03 | Shares 9,653
Planned sale 2 Sep 2025
Value US$13,250.38 | Price 12.43 | Shares 1,066
Proposed sale 2 Sep 2025
Value US$13,245.37 | Price 12.43 | Shares 1,066
Sale 25 Aug 2025
Value US$36,878.52 | Price 12.04 | Shares 3,063
Sale 25 Aug 2025
Value US$36,252.44 | Price 12.04 | Shares 3,011
Sale 25 Aug 2025
Value US$258,787.76 | Price 12.04 | Shares 21,494
Sale 25 Aug 2025
Value US$22,695.40 | Price 12.04 | Shares 1,885
Proposed sale 25 Aug 2025
Value US$258,757.67 | Price 12.04 | Shares 21,494
Proposed sale 25 Aug 2025
Value US$22,701.62 | Price 12.04 | Shares 1,885
Proposed sale 25 Aug 2025
Value US$36,882.81 | Price 12.04 | Shares 3,063
Proposed sale 25 Aug 2025
Value US$36,252.74 | Price 12.04 | Shares 3,011
Sale 2 Jun 2025
Value US$111,581.05 | Price 8.05 | Shares 13,861
Proposed sale 2 Jun 2025
Value US$111,524.22 | Price 8.05 | Shares 13,861
Sale 23 May 2025
Value US$21,323.58 | Price 7.17 | Shares 2,974
Sale 23 May 2025
Value US$13,350.54 | Price 7.17 | Shares 1,862
Sale 23 May 2025
Value US$21,712.32 | Price 7.18 | Shares 3,024
Sale 23 May 2025
Value US$152,352.42 | Price 7.18 | Shares 21,219
Proposed sale 23 May 2025
Value US$21,323.28 | Price 7.17 | Shares 2,974
Proposed sale 23 May 2025
Value US$21,706.88 | Price 7.18 | Shares 3,024
Proposed sale 23 May 2025
Value US$152,288.76 | Price 7.18 | Shares 21,219
Proposed sale 23 May 2025
Value US$13,346.82 | Price 7.17 | Shares 1,862
Buy 8 May 2025
Value US$69,600.00 | Price 6.96 | Shares 10,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-05 2026-06-03 S Sale
1.5
Waheed Nadia

Chief Medical Officer

Officer
39,453 -2.3%
254.12
US$1,960,410 		39,453 -2.3% 254.12 US$1,960,410
2026-06-05 2026-06-03 S Sale
1.5
Waheed Nadia

Chief Medical Officer

Officer
31,044 +32.7%
45.85
US$1,638,606 		31,044 +32.7% 45.85 US$1,638,606
2026-06-03 2026-06-03 PrS Proposed sale
1.5
NADIA K. WAHEED

Officer

Officer
60,171
256.20
US$1,088,067 		60,171 256.20 US$1,088,067
2026-05-28 2026-05-26 S Sale
3.0
Dugel Pravin

See Remarks

Executive Director
21,156 -0.8%
8.20
US$173,479 		21,156 -0.8% 8.20 US$173,479
2026-05-28 2026-05-26 S Sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
3,018 -0.9%
8.20
US$24,748 		3,018 -0.9% 8.20 US$24,748
2026-05-28 2026-05-26 S Sale
2.7
Kaiser Peter

Chief Development Officer

Officer
2,967 -1.1%
8.20
US$24,329 		2,967 -1.1% 8.20 US$24,329
2026-05-28 2026-05-26 S Sale
2.9
Nayak Sanjay

Chief Strategy Officer

Officer
1,858 -0.6%
8.20
US$15,236 		1,858 -0.6% 8.20 US$15,236
2026-05-26 2026-05-26 PrS Proposed sale
2.9
SANJAY NAYAK

Officer

Officer
1,858
8.20
US$15,237 		1,858 8.20 US$15,237
2026-05-26 2026-05-26 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
2,967
8.20
US$24,334 		2,967 8.20 US$24,334
2026-05-26 2026-05-26 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
3,018
8.20
US$24,745 		3,018 8.20 US$24,745
2026-05-26 2026-05-26 PrS Proposed sale
3.0
PRAVIN DUGEL

Officer

Officer
21,156
8.20
US$173,513 		21,156 8.20 US$173,513
2026-02-25 2026-02-23 S Sale
3.0
Dugel Pravin

See Remarks

Executive Director
20,056 -0.7%
8.28
US$166,064 		20,056 -0.7% 8.28 US$166,064
2026-02-25 2026-02-23 S Sale
2.7
Kaiser Peter

Chief Development Officer

Officer
2,810 -1.0%
8.28
US$23,267 		2,810 -1.0% 8.28 US$23,267
2026-02-25 2026-02-23 S Sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
3,057 -0.9%
8.28
US$25,312 		3,057 -0.9% 8.28 US$25,312
2026-02-25 2026-02-23 S Sale
2.9
Nayak Sanjay

Chief Strategy Officer

Officer
1,759 -0.5%
8.28
US$14,565 		1,759 -0.5% 8.28 US$14,565
2026-02-23 2026-02-23 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
2,810
8.28
US$23,268 		2,810 8.28 US$23,268
2026-02-23 2026-02-23 PrS Proposed sale
3.0
PRAVIN DUGEL

Officer

Officer
20,056
8.28
US$166,086 		20,056 8.28 US$166,086
2026-02-23 2026-02-23 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
3,057
8.28
US$25,298 		3,057 8.28 US$25,298
2026-02-23 2026-02-23 PrS Proposed sale
2.9
SANJAY NAYAK

Officer

Officer
1,759
8.28
US$14,563 		1,759 8.28 US$14,563
2026-02-24 2026-02-20 S Sale
1.5
Waheed Nadia

Chief Medical Officer

Officer
3,510 -1.1%
7.74
US$27,167 		3,510 -1.1% 7.74 US$27,167
2026-02-24 2026-02-20 B Purchase
3.4
LINDSTROM RICHARD L MD
Non-Executive Director
60,229 +32.3%
7.66
US$461,354 		60,229 +32.3% 7.66 US$461,354
2026-02-20 2026-02-20 PrS Proposed sale
1.5
NADIA K. WAHEED

Officer

Officer
3,510
7.74
US$27,170 		3,510 7.74 US$27,170
2026-02-17 2026-02-12 S Sale
2.2
Notman Donald

Chief Operating Officer

Officer
11,446 -3.0%
9.04
US$103,472 		11,446 -3.0% 9.04 US$103,472
2026-02-17 2026-02-12 S Sale
2.9
Nayak Sanjay

Chief Strategy Officer

Officer
10,348 -3.0%
9.04
US$93,546 		10,348 -3.0% 9.04 US$93,546
2026-02-17 2026-02-12 S Sale
3.0
Dugel Pravin

See Remarks

Executive Director
124,882 -4.0%
9.04
US$1,128,933 		124,882 -4.0% 9.04 US$1,128,933
2026-02-17 2026-02-12 S Sale
1.5
Waheed Nadia

Chief Medical Officer

Officer
7,863 -2.4%
9.04
US$71,082 		7,863 -2.4% 9.04 US$71,082
2026-02-12 2026-02-12 PrS Proposed sale
2.2
DONALD D NOTMAN JR.

Officer

Officer
11,446
9.04
US$103,481 		11,446 9.04 US$103,481
2026-02-12 2026-02-12 PrS Proposed sale
3.0
PRAVIN DUGEL

Officer

Officer
124,882
9.04
US$1,128,584 		124,882 9.04 US$1,128,584
2026-02-12 2026-02-12 PrS Proposed sale
STEVE MEYERS

Officer

Officer
6,864
9.04
US$62,034 		6,864 9.04 US$62,034
2026-02-12 2026-02-12 PrS Proposed sale
2.9
SANJAY NAYAK

Officer

Officer
10,348
9.04
US$93,560 		10,348 9.04 US$93,560
2026-02-12 2026-02-12 PrS Proposed sale
1.5
NADIA K. WAHEED

Officer

Officer
7,863
9.04
US$71,082 		7,863 9.04 US$71,082
2026-02-04 2026-02-04 S Sale
2.2
Notman Donald

Chief Operating Officer

Officer
6,035 -1.6%
8.54
US$51,539 		6,035 -1.6% 8.54 US$51,539
2026-02-04 2026-02-04 S Sale
2.2
Notman Donald

Chief Operating Officer

Officer
6,035 -1.6%
8.54
US$51,539 		6,035 -1.6% 8.54 US$51,539
2026-02-04 2026-02-04 PrS Proposed sale
STEVE MEYERS

Officer

Officer
4,408
8.54
US$37,636 		4,408 8.54 US$37,636
2026-02-04 2026-02-04 PrS Proposed sale
2.2
DONALD D NOTMAN JR.

Officer

Officer
6,035
8.54
US$51,541 		6,035 8.54 US$51,541
2026-02-04 2026-02-02 S Sale
2.2
Notman Donald

Chief Operating Officer

Officer
5,455 -1.4%
9.14
US$49,859 		5,455 -1.4% 9.14 US$49,859
2026-02-02 2026-02-02 PrS Proposed sale
2.2
DONALD D NOTMAN JR.

Officer

Officer
5,455
9.14
US$49,873 		5,455 9.14 US$49,873
2026-02-02 2026-02-02 PrS Proposed sale
STEVE MEYERS

Officer

Officer
3,052
9.14
US$27,904 		3,052 9.14 US$27,904
2025-11-26 2025-11-24 S Sale
2.7
Kaiser Peter

Chief Development Officer

Officer
3,007 -1.5%
12.02
US$36,144 		3,007 -1.5% 12.02 US$36,144
2025-11-26 2025-11-24 S Sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
3,469 -1.4%
12.04
US$41,767 		3,469 -1.4% 12.04 US$41,767
2025-11-26 2025-11-24 S Sale
2.9
Nayak Sanjay

Chief Strategy Officer

Officer
1,878 -0.7%
12.04
US$22,611 		1,878 -0.7% 12.04 US$22,611
2025-11-26 2025-11-24 S Sale
3.0
Dugel Pravin

See Remarks

Executive Director
19,530 -0.6%
12.04
US$235,141 		19,530 -0.6% 12.04 US$235,141
2025-11-24 2025-11-24 PrS Proposed sale
3.0
PRAVIN DUGEL

Officer

Officer
19,530
12.04
US$235,083 		19,530 12.04 US$235,083
2025-11-24 2025-11-24 PrS Proposed sale
2.9
SANJAY NAYAK

Officer

Officer
1,878
12.04
US$22,616 		1,878 12.04 US$22,616
2025-11-24 2025-11-24 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
3,007
12.02
US$36,150 		3,007 12.02 US$36,150
2025-11-24 2025-11-24 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
3,469
12.04
US$41,772 		3,469 12.04 US$41,772
2025-11-07 2025-11-05 S Sale
2.1
Saroj Namrata

Chief Business Officer

Officer
25,865 -12.9%
10.74
US$277,790 		25,865 -12.9% 10.74 US$277,790
2025-11-05 2025-11-05 PrS Proposed sale
2.1
NAMRATA SAROJ

Officer

Officer
25,865
10.74
US$277,909 		25,865 10.74 US$277,909
2025-10-10 2025-10-08 S Sale
3.1
Anderman Todd

Chief Legal Officer

Officer
11,132 -11.3%
12.34
US$137,369 		11,132 -11.3% 12.34 US$137,369
2025-10-08 2025-10-08 PrS Proposed sale
3.1
TODD ANDERMAN

Officer

Officer
11,132
12.34
US$137,400 		11,132 12.34 US$137,400
2025-10-06 2025-10-02 S Sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
10,502 -4.0%
11.04
US$115,942 		10,502 -4.0% 11.04 US$115,942
2025-10-06 2025-10-02 S Sale
2.7
Kaiser Peter

Chief Development Officer

Officer
9,653 -4.7%
11.03
US$106,473 		9,653 -4.7% 11.03 US$106,473
2025-10-02 2025-10-02 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
10,502
11.04
US$115,890 		10,502 11.04 US$115,890
2025-10-02 2025-10-02 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
9,653
11.03
US$106,516 		9,653 11.03 US$106,516
2025-09-04 2025-09-02 PlS Planned sale
2.2
Notman Donald

See Remarks

Officer
1,066 -0.3%
12.43
US$13,250 		1,066 -0.3% 12.43 US$13,250
2025-09-02 2025-09-02 PrS Proposed sale
2.2
DONALD D NOTMAN JR.

Officer

Officer
1,066
12.43
US$13,245 		1,066 12.43 US$13,245
2025-08-27 2025-08-25 S Sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
3,063 -1.2%
12.04
US$36,879 		3,063 -1.2% 12.04 US$36,879
2025-08-27 2025-08-25 S Sale
2.7
Kaiser Peter

Chief Development Officer

Officer
3,011 -1.5%
12.04
US$36,252 		3,011 -1.5% 12.04 US$36,252
2025-08-27 2025-08-25 S Sale
3.0
Dugel Pravin

See Remarks

Executive Director
21,494 -0.7%
12.04
US$258,788 		21,494 -0.7% 12.04 US$258,788
2025-08-27 2025-08-25 S Sale
2.9
Nayak Sanjay

Chief Strategy Officer

Officer
1,885 -0.7%
12.04
US$22,695 		1,885 -0.7% 12.04 US$22,695
2025-08-25 2025-08-25 PrS Proposed sale
3.0
PRAVIN DUGEL

Officer

Officer
21,494
12.04
US$258,758 		21,494 12.04 US$258,758
2025-08-25 2025-08-25 PrS Proposed sale
2.9
SANJAY NAYAK

Officer

Officer
1,885
12.04
US$22,702 		1,885 12.04 US$22,702
2025-08-25 2025-08-25 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
3,063
12.04
US$36,883 		3,063 12.04 US$36,883
2025-08-25 2025-08-25 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
3,011
12.04
US$36,253 		3,011 12.04 US$36,253
2025-06-03 2025-06-02 S Sale
1.5
Waheed Nadia

Chief Medical Officer

Officer
13,861 -6.3%
8.05
US$111,581 		13,861 -6.3% 8.05 US$111,581
2025-06-02 2025-06-02 PrS Proposed sale
1.5
NADIA K. WAHEED

Officer

Officer
13,861
8.05
US$111,524 		13,861 8.05 US$111,524
2025-05-27 2025-05-23 S Sale
2.7
Kaiser Peter

Chief Development Officer

Officer
2,974 -1.4%
7.17
US$21,324 		2,974 -1.4% 7.17 US$21,324
2025-05-27 2025-05-23 S Sale
2.9
Nayak Sanjay

Chief Strategy Officer

Officer
1,862 -0.7%
7.17
US$13,351 		1,862 -0.7% 7.17 US$13,351
2025-05-27 2025-05-23 S Sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
3,024 -1.1%
7.18
US$21,712 		3,024 -1.1% 7.18 US$21,712
2025-05-27 2025-05-23 S Sale
3.0
Dugel Pravin

See Remarks

Executive Director
21,219 -0.6%
7.18
US$152,352 		21,219 -0.6% 7.18 US$152,352
2025-05-23 2025-05-23 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
2,974
7.17
US$21,323 		2,974 7.17 US$21,323
2025-05-23 2025-05-23 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
3,024
7.18
US$21,707 		3,024 7.18 US$21,707
2025-05-23 2025-05-23 PrS Proposed sale
3.0
PRAVIN DUGEL

Officer

Officer
21,219
7.18
US$152,289 		21,219 7.18 US$152,289
2025-05-23 2025-05-23 PrS Proposed sale
2.9
SANJAY NAYAK

Officer

Officer
1,862
7.17
US$13,347 		1,862 7.17 US$13,347
2025-05-12 2025-05-08 B Purchase
3.4
LINDSTROM RICHARD L MD
Non-Executive Director
10,000 +6.1%
6.96
US$69,600 		10,000 +6.1% 6.96 US$69,600
Explore more

More insider trading research around Ocular Therapeutix Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America